EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Associations of Plasma Omega-3 Fatty Acid Levels and Reported Fish Oil Supplement Use with Depression and Anxiety: A Cross-Sectional Analysis from the United Kingdom Biobank

William S Harris, Wen-Chun Liu, Jason Westra, Nathan L Tintle, Prasad P Devarshi, Ryan W Grant, Susan Hazels Mitmesser, Kuan-Pin Su

The Journal of Nutrition · 2026

DOI: 10.1016/j.tjnut.2025.10.032 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift The Journal of Nutrition, 2026. Verfasst von William S Harris und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fatty Acid Research Institute, OmegaQuant Analytics, Sioux Falls, SD, United States; Department of Internal Medicine, Sanford School of Medicine, Uni…. Hauptthemen laut MEDLINE: Fish Oils, Dietary Supplements, Fatty Acids, Omega-3, Depression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pharmavite LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The role that marine omega-3 (n-3) polyunsaturated fatty acids (PUFAs) may play in reducing the risk for developing depression and/or anxiety is unclear. OBJECTIVES: The present study examined the relationships between plasma levels of total omega-3 PUFAs, docosahexaenoic acid (DHA), and the non-DHA ω-3 PUFAs with medical record-documented depression and/or anxiety (both historical and recent, within the last 12 mo) in the United Kingdom Biobank. The associations of these outcomes with the reported use of fish oil supplements (FOS) were also examined. METHODS: Information from 258,354 participants who had data on plasma ω-3 PUFA levels and all covariates were used for the biomarker-based analyses, and data from 468,145 people who reported FOS use at baseline were used in the latter analysis. RESULTS: We found that all 3 ω-3 PUFA metrics were inversely associated with a history of both depression and anxiety. Specifically, risk for the former outcome was between 15% and 33% lower in Q5 compared with Q1, and for the latter outcome, between 19% and 22% lower comparing Q5 with Q1. Risk for recent depression was 29% and 32% lower (Q5 compared with Q1) for total ω-3 PUFAs and for non-DHA, respectively. FOS use was associated with a 9%-10% lower risk for a history of depression and anxiety, respectively, and a 20% lower risk for recent anxiety. CONCLUSIONS: We found evidence that higher levels of ω-3 PUFAs may play a protective role in depression and anxiety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fish OilsDietary SupplementsFatty Acids, Omega-3DepressionAnxietyHumansUnited KingdomFemaleMaleMiddle AgedCross-Sectional StudiesAgedAdultBiological Specimen BanksDocosahexaenoic Acids

Stichwörter der Autor:innen

biomarkersepidemiologymental healthobservational cohortomega-3 fatty acids

Substanzen

Fish OilsFatty Acids, Omega-3Docosahexaenoic Acids

Autor:innen und Institutionen

  • Fatty Acid Research Institute, OmegaQuant Analytics, Sioux Falls, SD, United States; Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, United States. Electronic ad…
  • Department of Nursing, National Tainan Junior College of Nursing, Tainan, Taiwan.
  • Fatty Acid Research Institute, OmegaQuant Analytics, Sioux Falls, SD, United States.
  • Fatty Acid Research Institute, OmegaQuant Analytics, Sioux Falls, SD, United States; Department of Population Health Nursing Science, College of Nursing, University of Illinois - Chicago, Chicago, IL, United States.
  • Science and Technology, Pharmavite, LLC, West Hills, CA, United States.
  • Department of Psychiatry and Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan; Department of Allergy, Immunology, and Rheumatology, Tungs' Taichung Metro Harbor Hospital, Tai…

Förderung

  • Pharmavite LLC

Zitieren

APA

Harris, W. S., Liu, W. C., Westra, J., Tintle, N. L., Devarshi, P. P., Grant, R. W., Mitmesser, S. H., & Su, K. P. (2026). Associations of Plasma Omega-3 Fatty Acid Levels and Reported Fish Oil Supplement Use with Depression and Anxiety: A Cross-Sectional Analysis from the United Kingdom Biobank. The Journal of Nutrition. https://doi.org/10.1016/j.tjnut.2025.10.032

Vancouver

Harris WS, Liu WC, Westra J, Tintle NL, Devarshi PP, Grant RW, et al. Associations of Plasma Omega-3 Fatty Acid Levels and Reported Fish Oil Supplement Use with Depression and Anxiety: A Cross-Sectional Analysis from the United Kingdom Biobank. The Journal of Nutrition. 2026. doi:10.1016/j.tjnut.2025.10.032

BibTeX
@article{Harris2026,
  author = {Harris, William S and Liu, Wen-Chun and Westra, Jason and Tintle, Nathan L and Devarshi, Prasad P and Grant, Ryan W and Mitmesser, Susan Hazels and Su, Kuan-Pin},
  title = {Associations of Plasma Omega-3 Fatty Acid Levels and Reported Fish Oil Supplement Use with Depression and Anxiety: A Cross-Sectional Analysis from the United Kingdom Biobank},
  journal = {The Journal of Nutrition},
  year = {2026},
  doi = {10.1016/j.tjnut.2025.10.032}
}
Kostenlos starten →